MGC Diagnostics Corporation
MGCD
MGCD was delisted on the 28th of December, 2017.
17 hedge funds and large institutions have $5.86M invested in MGC Diagnostics Corporation in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
11% less funds holding
Funds holding: 19 → 17 (-2)
25% less capital invested
Capital invested by funds: $7.78M → $5.86M (-$1.93M)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$133K |
| 2 |
PA
Perceptive Advisors
New York
|
+$85.4K |
| 3 |
PM
Platinum Management
New York
|
+$80.4K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$24.8K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$15.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$588K |
| 2 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$195K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$23.5K |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$9.11K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8K |
MGCD Hedge Fund Activity: Q3 2014 in Review
17 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q3 2014, worth a combined $5.86M — down 25% from $7.78M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MGCD and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $133K. The largest seller was Perritt Capital Management, exiting entirely with an estimated $588K sold.
- 17 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q3 2014, down from 19 in Q2 2014.
- Funds reported $5.86M of MGC Diagnostics Corporation stock for Q3 2014, down 25% quarter-over-quarter.
- 3 funds opened new MGC Diagnostics Corporation positions in Q3 2014 and 4 closed out, a net change of -1 holder.
- The largest MGC Diagnostics Corporation buyer in Q3 2014 was Vanguard Group, an estimated $133K added.
- The largest MGC Diagnostics Corporation seller in Q3 2014 was Perritt Capital Management, an estimated $588K sold.
Based on aggregated 13F filings for Q3 2014.